Cargando…
Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study
OBJECTIVE: To examine admission trends, complications, and costs for inpatient infantile hemangioma (IH) associated with propranolol therapy utilizing the Pediatric Health Information System (PHIS) database. Study Design. A retrospective cohort study was completed using the PHIS database. The PHIS d...
Autores principales: | Abu-Rmaileh, Muhammad, Hairston, Hayden C., Zaniletti, Isabella, Kompelli, Anvesh, Davis, Kyle P., Gardner, James Reed, Bolin, Elijah H., Richter, Gresham T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481381/ https://www.ncbi.nlm.nih.gov/pubmed/36119548 http://dx.doi.org/10.1155/2022/4423558 |
Ejemplares similares
-
Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development
por: Giese, Rachel A., et al.
Publicado: (2021) -
Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas
por: Phillips, James D., et al.
Publicado: (2021) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration
por: Gomez-Acevedo, Horacio, et al.
Publicado: (2020) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)